A detailed history of Lowe Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lowe Wealth Advisors, LLC holds 95 shares of ABBV stock, worth $17,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares
95
Previous 70 35.71%
Holding current value
$17,470
Previous $13,000 23.08%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$164.99 - $203.87 $4,124 - $5,096
25 Added 35.71%
95 $16,000
Q3 2024

Oct 02, 2024

BUY
$163.84 - $199.33 $11,468 - $13,953
70 New
70 $13,000
Q1 2023

Apr 05, 2023

SELL
$144.61 - $166.54 $40,490 - $46,631
-280 Reduced 58.95%
195 $31,000
Q2 2022

Jul 07, 2022

SELL
$137.62 - $174.96 $6,881 - $8,748
-50 Reduced 9.52%
475 $73,000
Q3 2021

Oct 05, 2021

SELL
$106.4 - $120.78 $10,640 - $12,078
-100 Reduced 16.0%
525 $57,000
Q2 2021

Jul 01, 2021

BUY
$105.21 - $117.21 $26,302 - $29,302
250 Added 66.67%
625 $70,000
Q2 2020

Jul 08, 2020

SELL
$73.37 - $98.18 $2,567 - $3,436
-35 Reduced 8.54%
375 $37,000
Q4 2019

Jan 15, 2020

SELL
$72.13 - $90.25 $10,819 - $13,537
-150 Reduced 26.79%
410 $36,000
Q3 2019

Oct 08, 2019

BUY
$62.98 - $75.72 $6,298 - $7,572
100 Added 21.74%
560 $42,000
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $20,367 - $26,033
310 Added 206.67%
460 $33,000
Q4 2017

Jan 18, 2018

SELL
$89.56 - $98.21 $4,478 - $4,910
-50 Reduced 25.0%
150 $15,000
Q3 2017

Oct 05, 2017

BUY
$69.85 - $89.22 $13,969 - $17,844
200
200 $18,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lowe Wealth Advisors, LLC Portfolio

Follow Lowe Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Wealth Advisors, LLC with notifications on news.